{"date":"2026-08-04","count":40,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6844-2026-08-04-1958-sqgrt0","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"19:58:45","subject":"公告本公司法人董事代表人異動","clause":"第6款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-08-04 19:58，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-08-04-1958-37n2dy","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"19:58:34","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-08-04 19:58，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-08-04-1911-1saqsek","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"19:11:18","subject":"公告本公司訂定減資換股基準日及減資換股作業計畫等相關事宜","clause":"第11款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-08-04 19:11，「公告本公司訂定減資換股基準日及減資換股作業計畫等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-04-1908-xl23bz","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"19:08:09","subject":"代重要子公司益邦製藥股份有限公司公告現金股利配息基準日","clause":"第14款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-04 19:08，「代重要子公司益邦製藥股份有限公司公告現金股利配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-08-04-1838-1b9r7vd","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"18:38:59","subject":"公告本公司115年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-08-04 18:38，「公告本公司115年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-08-04-1827-1q6wz7h","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"18:27:39","subject":"公告本公司人事異動","clause":"第8款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-04 18:27，「公告本公司人事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-08-04-1805-1j343pa","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-08-04","time":"18:05:02","subject":"本公司接獲衛福部來函，針對AC-1101治療圓禿症第2a期臨床試驗，需補充檢測資料及臨床試驗納入條件，本公司預計於近期內提供補充資料並進行申復。","clause":"第8款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-08-04 18:05，「本公司接獲衛福部來函，針對AC-1101治療圓禿症第2a期臨床試驗，需補充檢測資料及臨床試驗納入條件，本公司預計於近期內」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-08-04-1746-rk1c04","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"17:46:31","subject":"代重要子公司永信藥品工業股份有限公司公告對關係人之捐贈","clause":"第43款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-08-04 17:46，「代重要子公司永信藥品工業股份有限公司公告對關係人之捐贈」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-08-04-1746-14bnm4x","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"17:46:07","subject":"代重要子公司永信藥品工業股份有限公司公告董事會重要決議事項","clause":"第51款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-08-04 17:46，「代重要子公司永信藥品工業股份有限公司公告董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-08-04-1737-m6sb3d","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"17:37:01","subject":"公告本公司民國115年第二季財務報告董事會預計召開日期為115年8月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-08-04 17:37，「公告本公司民國115年第二季財務報告董事會預計召開日期為115年8月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-08-04-1721-9gxzmk","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"17:21:32","subject":"公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-08-04 17:21，「公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-08-04-1710-9gxzmk","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"17:10:23","subject":"公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-08-04 17:10，「公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-08-04-1705-1iazxk7","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"17:05:58","subject":"115年第二季財務報告董事會預計召開日期為115年08月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-08-04 17:05，「115年第二季財務報告董事會預計召開日期為115年08月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-08-04-1701-1hxgux8","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"17:01:10","subject":"公告本公司民國115年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-08-04 17:01，「公告本公司民國115年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-08-04-1658-1t7lxh4","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"16:58:18","subject":"本公司民國115年第二季財務報告之董事會預計召開日期為民國115年08月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-08-04 16:58，「本公司民國115年第二季財務報告之董事會預計召開日期為民國115年08月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-08-04-1649-ssacpc","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:49:47","subject":"公告本公司董事長決議115年配息基準日","clause":"第14款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-08-04 16:49，「公告本公司董事長決議115年配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-08-04-1634-1biylag","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-08-04","time":"16:34:27","subject":"公告本公司發言人、財務主管暨會計主管異動案。","clause":"第11款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-08-04 16:34，「公告本公司發言人、財務主管暨會計主管異動案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-08-04-1634-17qvvm5","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-08-04","time":"16:34:08","subject":"公告本公司董事會通過115年第二季財務報告","clause":"第43款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-08-04 16:34，「公告本公司董事會通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-08-04-1633-1h35re4","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-08-04","time":"16:33:22","subject":"公告本公司115年08月04日董事會重要決議事項","clause":"第44款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-08-04 16:33，「公告本公司115年08月04日董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-08-04-1633-1h1nkbx","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-04","time":"16:33:18","subject":"本公司受邀參加台中銀證券舉辦之法人說明會","clause":"第44款","fact_date":"2026-08-05","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-08-04 16:33，「本公司受邀參加台中銀證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-08-04-1631-s5uciy","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:31:58","subject":"公告本公司營運長、財務主管、公司治理主管、代理發言人異動","clause":"第8款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-08-04 16:31，「公告本公司營運長、財務主管、公司治理主管、代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-08-04-1631-qtquwd","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:31:42","subject":"本公司115年第2季合併財務報告提報董事會預計召開日期為115年8月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-08-04 16:31，「本公司115年第2季合併財務報告提報董事會預計召開日期為115年8月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-08-04-1624-yvttio","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:24:58","subject":"本公司董事會決議通過放棄認購子公司台灣味群工業股份有限公司現金增資案","clause":"第53款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-08-04 16:24，「本公司董事會決議通過放棄認購子公司台灣味群工業股份有限公司現金增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-08-04-1624-6zb90s","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:24:25","subject":"公告本公司董事會通過115年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-08-04 16:24，「公告本公司董事會通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-08-04-1621-1qytcve","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:21:40","subject":"公告本公司董事會通過對關係人捐贈事宜","clause":"第43款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-08-04 16:21，「公告本公司董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-08-04-1620-100esni","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:20:45","subject":"公告本公司研發主管異動","clause":"第8款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-08-04 16:20，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-08-04-1612-37n2dy","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:12:48","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-08-04 16:12，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-08-04-1612-yniuci","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:12:23","subject":"公告本公司董事會通過115年度第二季合併財務報告","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-08-04 16:12，「公告本公司董事會通過115年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-08-04-1611-1r3zinn","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"16:11:37","subject":"公告本公司董事會決議現金股利除息基準日","clause":"第14款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-08-04 16:11，「公告本公司董事會決議現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-08-04-1558-w0wr17","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"15:58:26","subject":"公告本公司民國115年度第二季合併財務報告業經提報董事會","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-08-04 15:58，「公告本公司民國115年度第二季合併財務報告業經提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-08-04-1550-1b9r7vd","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"15:50:22","subject":"公告本公司115年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-08-04 15:50，「公告本公司115年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-08-04-1535-4mya1d","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"15:35:10","subject":"公告本公司董事會通過115年第2季財務報表","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-08-04 15:35，「公告本公司董事會通過115年第2季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-08-04-1531-1jf9iw7","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-08-04","time":"15:31:58","subject":"公告本公司115年第2季合併財務報告提報董事會","clause":"第43款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-08-04 15:31，「公告本公司115年第2季合併財務報告提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-08-04-1444-dvjshv","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"14:44:17","subject":"公告本公司115年第2季財務報告董事會預計召開日期為115年8月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-08-04 14:44，「公告本公司115年第2季財務報告董事會預計召開日期為115年8月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-08-04-1438-5aj7fs","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"14:38:13","subject":"公告本公司調整現金增資之每股發行價格","clause":"第11款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-08-04 14:38，「公告本公司調整現金增資之每股發行價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2026-08-04-1417-1y7uii1","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"14:17:41","subject":"公告本公司115年第2季財務報告董事會預計召開日期為115年08月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2026-08-04 14:17，「公告本公司115年第2季財務報告董事會預計召開日期為115年08月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-08-04-1412-1rluwan","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-08-04","time":"14:12:25","subject":"公告115年第二季財務報告董事會召開日期為115年8月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-08-04 14:12，「公告115年第二季財務報告董事會召開日期為115年8月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-08-04-1404-15nc5kv","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"14:04:14","subject":"補充說明本公司董事會決議發行國內第一次有擔保轉換公司債","clause":"第11款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-08-04 14:04，「補充說明本公司董事會決議發行國內第一次有擔保轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-08-04-1203-unxunf","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-08-04","time":"12:03:20","subject":"公告本公司115年第二季財務報告董事會預計召開日期為115年08月12日","clause":"第31款","fact_date":"2026-08-04","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-08-04 12:03，「公告本公司115年第二季財務報告董事會預計召開日期為115年08月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-04-1041-54swv6","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-04","time":"10:41:31","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-04 10:41，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}